A 1 year follow-up study to the G304 study to demonstrate the efficacy of the Grass MATA MPL (0.5 mL)
Latest Information Update: 09 Jan 2015
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary) ; Monophosphoryl lipid A
- Indications Grass pollen hypersensitivity
- Focus Therapeutic Use
- Sponsors Allergy Therapeutics
Most Recent Events
- 09 Jan 2015 New trial record